SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Life-Extending Protein Can Also Have Damaging Effects on Brain Cells, University of Southern California Study
July 2, 2008
 · 
1 min read
Drug Development
Cells in Blood May Help Cancers Spread, University of North Carolina Researchers Say
July 2, 2008
 · 
1 min read
Drug Development
Caffeine Could Stave Off Multiple Sclerosis, Oklahoma Medical Research Foundation (OMRF) Researchers Say
July 1, 2008
 · 
1 min read
Drug Development
Transplant Drug May Ease Disorder Linked to Autism, University of California, Los Angeles (UCLA) Scientists Find
July 1, 2008
 · 
1 min read
Drug Development
A Single Mechanism for Hypertension, Insulin Resistance and Immune Suppression Found in University of California, San Diego (UCSD) Study
June 30, 2008
 · 
1 min read
Drug Development
Accidental Fungus Leads to Promising Cancer Drug, Data Presented in Nature Biotechnology Journal
June 30, 2008
 · 
1 min read
Drug Development
Cancer Cure which Worked on Mice in Wake Forest University Study will be Tested on Humans
June 30, 2008
 · 
1 min read
Drug Development
Fake Virus Tested at State University of New York Could Make Safe New Vaccines
June 30, 2008
 · 
1 min read
Drug Development
Umbilical Cord Blood Cell Transplants May Help ALS Patients, University of South Florida Study Shows
June 27, 2008
 · 
1 min read
Drug Development
Researchers at Dana-Farber Cancer Institute Identify Promising Cancer Drug Target in Prostate Tumors
June 27, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147
January 8, 2026
 · 
7 min read
Press Releases
Espervita’s EVT0185 Demonstrates Reversal of Metabolic Dysfunction and Liver Fibrosis in Cell Metabolism Publication
January 7, 2026
 · 
2 min read
Press Releases
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
January 6, 2026
 · 
5 min read
Press Releases
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
January 6, 2026
 · 
10 min read
Press Releases
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)
January 5, 2026
 · 
6 min read
Press Releases
Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator
January 5, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
January 5, 2026
 · 
6 min read
Press Releases
Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology
December 23, 2025
 · 
3 min read
Press Releases
Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026
December 22, 2025
 · 
3 min read
Press Releases
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
December 18, 2025
 · 
14 min read
Press Releases
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
December 18, 2025
 · 
2 min read
Press Releases
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World’s First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours
December 18, 2025
 · 
4 min read
Press Releases
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World’s First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
December 16, 2025
 · 
4 min read
Press Releases
Feinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung Injury
December 16, 2025
 · 
4 min read
Press Releases
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
December 16, 2025
 · 
6 min read
Press Releases
Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models
December 15, 2025
 · 
2 min read
Press Releases
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
December 12, 2025
 · 
5 min read
Press Releases
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).
December 12, 2025
 · 
3 min read
Press Releases
NiKang Therapeutics Presents Discovery of NKT5097, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2/4 Dual Degrader for Cancer Therapy at SABCS 2025
December 12, 2025
 · 
3 min read
Press Releases
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
December 12, 2025
 · 
6 min read
Load More